NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/05/2023
Voltar para busca
Dado oficial do USPTO
QVEKLY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
23/05/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
28/03/2019
Data de registro
23/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/05/2023
Última transação
23/05/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Hellerup, DK
Examinador
LORENZO, GEORGE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Ascendis Pharma Endocrinology Division A/S
Representantes
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of growth disorderspharmaceutical preparations for the treatment of endocrine disorderspharmaceutical preparations for the treatment of bone disorders; diagnostic preparations for medical usediagnostic preparations for identifying and detecting growth hormone deficiencyendocrine disordersbone disorderscancerinfectious diseases
Classe 9
Downloadable computer software and downloadable computer programs for use in providing medical advice and advice on medications for treatmentpatient assistance and health insurance in the field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for sharing information related to growth disordersendocrine disordersbone disorderscancerinfectious diseases and the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases for use by patients with growth hormone disordershypoparathyroidismskeletal dysplasiadiabetes in the medical field of growth disordersendocrine disordersbone disorderscancerinfectious diseases; downloadable computer application software for mobile phonestablet computers handheld computers and personal computersdownloadable software that coordinates the delivery of health care services between health care providerspatients and those parties responsible for the payment of health care servicesdownloadable software that allows individuals seeking medical educationinformation and services to locate a physician and treatment facility in their geographic area for medical treatment and allows physicians and health care professionals to communicate their credentials and specialization to patients and parties responsible for payment of healthcare services; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersdownloadable software that enables health care providers to monitor patientscommunicate clinical information relevant to a patient's careprovide and exchange information concerning patients and the health care services provided to patients; downloadable softwaredownloadable software applications and downloadable mobile applications for providing co-pay and other financial or medical access support; downloadable computer software for providing a communications platform enabling users to share health and healthcare information; downloadable softwaredownloadable software applications and downloadable mobile applications for the measurement of heightweightblood pressureserum calciumblood glucoseheart rate; downloadable softwaredownloadable software applications and downloadable mobile applications for providingexchangingretrieving and analyzing health and healthcare information; downloadable software for medical purposesfor formattingviewing and transmitting medical data collected and stored on hormone injection pens and pumps and between said injection pens and pumps and portable electronic devices; downloadable computer application software for mobile phonestablet computershandheld computers and personal computersa downloadable software application for providing healthcare-related informationmedication reminderstracking medication dosing history; the foregoing downloadable software related to pharmaceutical preparations for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases
Classe 10
Medical devices for injectiondosage and control of pharmaceuticalsmedical devices for injectiondosage measurement and monitoring of pharmaceuticals for the treatment of growth disordersendocrine disordersbone disorderscancerinfectious diseases; syringes for medical purposes and for injections; syringes for injection for medical and surgical usesyringes in the form of pens for surgical use; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with management of growth hormone disordershypoparathyroidismskeletal dysplasiacancer and diabetes; medical apparatusinfusion and injection devices for administering drugs; medical apparatus for diagnostic purposesmedicine dosage dispensers containing software featuring web-based medical information for physical and psychological examination and assessment of patients remotely and at a clinic; dosage management dispensers containing software for medical information management for guidance and control of medicines and for therapeutic use in web-based physical and psychological examination and assessment of patients remotely and at a clinic
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
23/05/2023
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
20/04/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
13/04/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
13/04/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/10/2022
EX5G
SOU EXTENSION 5 GRANTED
25/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
17/10/2022
EXT5
SOU EXTENSION 5 FILED
07/10/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/04/2022
EX4G
SOU EXTENSION 4 GRANTED
12/04/2022
EXT4
SOU EXTENSION 4 FILED
12/04/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/09/2021
EX3G
SOU EXTENSION 3 GRANTED
14/09/2021
EXT3
SOU EXTENSION 3 FILED
14/09/2021
EEXT
SOU TEAS EXTENSION RECEIVED
14/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/04/2021
EX2G
SOU EXTENSION 2 GRANTED
12/04/2021
EXT2
SOU EXTENSION 2 FILED
12/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/10/2020
EX1G
SOU EXTENSION 1 GRANTED
13/10/2020
EXT1
SOU EXTENSION 1 FILED
13/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
13/10/2020
DOCK
ASSIGNED TO EXAMINER
04/06/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/02/2020
PUBO
PUBLISHED FOR OPPOSITION
18/02/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/01/2020
ALIE
ASSIGNED TO LIE
07/01/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
16/12/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
13/09/2019
GNSL
LETTER OF SUSPENSION E-MAILED
13/09/2019
CNSL
SUSPENSION LETTER WRITTEN
13/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/06/2019
GNSL
LETTER OF SUSPENSION E-MAILED
12/06/2019
CNSL
SUSPENSION LETTER WRITTEN
12/06/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/06/2019
GNRT
NON-FINAL ACTION E-MAILED
11/06/2019
CNRT
NON-FINAL ACTION WRITTEN
11/06/2019
DOCK
ASSIGNED TO EXAMINER
09/06/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/04/2019
NWAP
NEW APPLICATION ENTERED
01/04/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace QVEKLY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.